PLA2G7 anticorps
-
- Antigène Voir toutes PLA2G7 (Lp-PLA2) Anticorps
- PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp PLA2G7 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Réactivité croisée
- Humain, Souris
- Purification
- Protein G purified
- Immunogène
- Recombinant LP-PLA2 Protein
- Clone
- 2A1B6
- Isotype
- IgG1, IgG1 kappa
- Top Product
- Discover our top product Lp-PLA2 Anticorps primaire
-
anti-Lipoprotein-Associated phospholipase A2 (Lp-PLA2) (AA 301-441) antibody
Lp-PLA2 Reactivité: Humain, Souris, Rat, Porc, Lapin WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Hôte: Lapin Polyclonal unconjugated
anti-Lipoprotein-Associated phospholipase A2 (Lp-PLA2) (AA 200-228) antibodyLp-PLA2 Reactivité: Humain WB, FACS, IHC (p) Hôte: Lapin Polyclonal RB21322 unconjugated
anti-Lipoprotein-Associated phospholipase A2 (Lp-PLA2) (AA 22-441) antibodyLp-PLA2 Reactivité: Humain WB, ELISA, IHC, ICC Hôte: Souris Monoclonal 3E1G5 unconjugated
anti-Lipoprotein-Associated phospholipase A2 (Lp-PLA2) (AA 49-441) antibodyLp-PLA2 Reactivité: Humain WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
anti-Lipoprotein-Associated phospholipase A2 (Lp-PLA2) (AA 22-441) antibodyLp-PLA2 Reactivité: Humain WB, ELISA Hôte: Souris Monoclonal 3D12B11 unconjugated
anti-Lipoprotein-Associated phospholipase A2 (Lp-PLA2) (AA 22-441) antibodyLp-PLA2 Reactivité: Humain ELISA Hôte: Souris Monoclonal 5D1 unconjugated
anti-Lipoprotein-Associated phospholipase A2 (Lp-PLA2) (AA 22-441) antibodyLp-PLA2 Reactivité: Humain WB, IHC, ICC Hôte: Lapin Polyclonal unconjugated
anti-Lipoprotein-Associated phospholipase A2 (Lp-PLA2) (AA 22-444) antibodyLp-PLA2 Reactivité: Chien WB, IHC, ICC Hôte: Lapin Polyclonal unconjugated
anti-Lipoprotein-Associated phospholipase A2 (Lp-PLA2) (AA 207-236), (Middle Region) antibodyLp-PLA2 Reactivité: Humain WB, FACS, IHC (p) Hôte: Lapin Polyclonal unconjugated
anti-Lipoprotein-Associated phospholipase A2 (Lp-PLA2) (AA 22-440) antibodyLp-PLA2 Reactivité: Souris WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
- Recommended dilution:WB:1:500-1:5000,IHC:1:50-1:500,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
- Autre désignation
- PLA2G7 (Lp-PLA2 Produits)
- Synonymes
- anticorps LDL-PLA2, anticorps LP-PLA2, anticorps PAFAD, anticorps PAFAH, anticorps Lp-PLA2, anticorps PAF-AH, anticorps R75400, anticorps zgc:77563, anticorps phospholipase A2 group VII, anticorps phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma), anticorps PLA2G7, anticorps Pla2g7, anticorps pla2g7
- Sujet
-
Background: Platelet-activating factor acetylhydrolase deficiency (PAFAD) : An enzymatic deficiency that results in exacerbated bodily response to inflammatory agents. It can be associated with several disease states including inflammatory gastrointestinal disorders, asthma and atopy. Asthmatic individuals with PAFAD may manifest aggravated respiratory symptoms.
Aliases: PLA2G7, PAFAH, LP-PLA2
- UniProt
- Q13093
- Pathways
- Peptide Hormone Metabolism
-
